Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

​Eascra Biotech is an early-stage nanomedicine company based in Boston, MA, developing Janus Base Nanoparticles (JBNps) inspired by DNA. These non-lipid nanoparticles offer enhanced stability, biocompatibility, and targeted delivery for therapeutics, including RNA, proteins, and small molecules. JBNps can penetrate challenging tissues like cartilage, brain, kidneys, and ECM-rich tumors. Their unique structure minimizes immun...
​Eascra Biotech is an early-stage nanomedicine company based in Boston, MA, developing Janus Base Nanoparticles (JBNps) inspired by DNA. These non-lipid nanoparticles offer enhanced stability, biocompatibility, and targeted delivery for therapeutics, including RNA, proteins, and small molecules. JBNps can penetrate challenging tissues like cartilage, brain, kidneys, and ECM-rich tumors. Their unique structure minimizes immunogenicity and toxicity, enabling room-temperature stability and efficient endocytosis. Eascra collaborates with NASA, the ISS National Lab, and Axiom Space to advance drug delivery solutions for hard-to-treat diseases.

List your booth number for exhibitions, ask us